Lavanya Visvabharathy, a T cell immunologist at Northwestern University, Chicago, has led extensive studies into Long Covid, but we learned that some of those studies, despite their merit and rigour, were proving hard to publish in top tier medical journals.  In this week's episode we lift the lid on the process of scientific publishing, talking through the challenges that Visvabharathy has faced trying to publish Long Covid research, the peer review process and the political landscape of the scientific research world.  Her latest paper, despite almost a two year delay, is published this week in Frontiers in Immunology.Living with Long Covid? How was your week?Website - https://www.tlcsessions.net/Twitter - @SessionsTlc https://twitter.com/sessionstlcInsta - @tlcsessions https://www.instagram.com/tlcsessions